Drazek E S, Stein D C, Deal C D
Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, USA.
J Bacteriol. 1995 May;177(9):2321-7. doi: 10.1128/jb.177.9.2321-2327.1995.
The gonococcal lsi-6 locus was cloned and shown by DNA sequence analysis to have homology with the E. coli rfaD gene, which encodes ADP-L-glycero-D-mannoheptose epimerase. This enzyme is involved in the biosynthesis of the lipopolysaccharide precursor ADP-L-glycero-D-mannoheptose. A site-directed frameshift mutation in lsi-6 was constructed by PCR amplification and introduced into the chromosome of Neisseria gonorrhoeae MS11 P+ by transformation. The lipooligosaccharides (LOS) of mutant and parental strains were characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The lsi-6 mutant produced LOS components with apparent molecular masses of 2.6 and 3.6 kDa as compared with a 3.6-kDa band of the MS11 P+ strain. The parental LOS phenotype was expressed when a revertant was constructed by transformation of the cloned wild-type gene into the lsi-6 mutant. The immunoreactivity of LOS from parental and constructed strains was examined by SDS-PAGE and Western blotting. Only the parental and reconstructed wild-type strains produced a 3.6-kDa LOS component that reacted with monoclonal antibody 2-1-L8. These results suggest that the lsi-6 locus is involved in gonococcal LOS biosynthesis and that the nonreactive mutant 3.6-kDa LOS component contains a conformational change or altered saccharide composition that interferes with immunoreactivity.
淋病奈瑟菌lsi-6基因座被克隆,通过DNA序列分析表明其与大肠杆菌rfaD基因具有同源性,该基因编码ADP-L-甘油-D-甘露庚糖表异构酶。这种酶参与脂多糖前体ADP-L-甘油-D-甘露庚糖的生物合成。通过PCR扩增构建lsi-6中的定点移码突变,并通过转化将其引入淋病奈瑟菌MS11 P+的染色体中。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)对突变株和亲本株的脂寡糖(LOS)进行表征。与MS11 P+菌株的3.6 kDa条带相比,lsi-6突变体产生了表观分子量为2.6和3.6 kDa的LOS组分。当通过将克隆的野生型基因转化到lsi-6突变体中构建回复株时,亲本LOS表型得以表达。通过SDS-PAGE和蛋白质印迹法检测亲本菌株和构建菌株的LOS的免疫反应性。只有亲本菌株和重建的野生型菌株产生了与单克隆抗体2-1-L8反应的3.6 kDa LOS组分。这些结果表明,lsi-6基因座参与淋病奈瑟菌LOS的生物合成,并且无反应性的突变体3.6 kDa LOS组分包含构象变化或改变的糖组成,从而干扰免疫反应性。